Skip to Content
Find More Like This
Return to Search

Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma

United States Patent

August 19, 2014
View the Complete Patent at the US Patent & Trademark Office
Lawrence Berkeley National Laboratory - Visit the Technology Transfer and Intellectual Property Management Department Website
A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.
Desprez; Pierre-Yves (Richmond, CA), Campisi; Judith (Berkeley, CA)
California Pacific Medical Center Research Institute (San Francisco, CA), The Regents of the University of California (Oakland, CA)
13/ 252,148
October 3, 2011
STATEMENT OF GOVERNMENTAL SUPPORT This invention was made with government support under Contract No. DE-AC03-765F00098, now Contract No. DE-AC02-05CH11231, awarded by the United States Department of Energy, and under NIH Grant for NCI RO1CA82548. The Government has certain rights in this invention.